Literature DB >> 3758053

Incidence and significance of candida antigen in low-risk and high-risk patient populations.

M F Price, L O Gentry.   

Abstract

A latex agglutination test which detects candida antigen in patients with disseminated infection was used to screen 328 patients. Of these patients 100 had renal failure but no signs or symptoms of candida infection, and 100 had high rheumatoid factor titers but also no signs or symptoms of candida infection. The remaining 128 patients were considered at high risk of developing systemic candida infection. Sequential titers were also determined in a number of these patients. The incidence of candida antigen titers greater than or equal to 1:4 in the low-risk population was 3% as compared to 53% in the high-risk group. None of the patients with positive rheumatoid factor titers had candida antigen titers greater than or equal to 1:2, however 13% had nonspecific agglutination at titers greater than 1:2. The incidence of nonspecific agglutination increased with increasing rheumatoid factor titers. In general the candida antigen titers correlated well with clinical findings and with the course of infection in those patients in whom sequential candida antigen titers were determined. This latex test thus appears to be a useful adjunct procedure for the diagnosis of serious candida infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758053     DOI: 10.1007/bf02075697

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  3 in total

1.  The compromised host and infection. II. Deep fungal infection.

Authors:  P D Hart; E Russell; J S Remington
Journal:  J Infect Dis       Date:  1969-08       Impact factor: 5.226

2.  Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis.

Authors:  J P Burnie; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

3.  Latex agglutination test for detection of Candida antigen in patients with disseminated disease.

Authors:  L O Gentry; I D Wilkinson; A S Lea; M F Price
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

  3 in total
  7 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay.

Authors:  M L Sanchez; M A Pfaller; I Cabezudo; M Bale; B Buschelman
Journal:  Mycopathologia       Date:  1992-06       Impact factor: 2.574

3.  Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients.

Authors:  I Cabezudo; M Pfaller; T Gerarden; F Koontz; R Wenzel; R Gingrich; K Heckman; C P Burns
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

Review 4.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

5.  Relation between stage of endogenous fungal endophthalmitis and prognosis.

Authors:  Hiroshi Takebayashi; Atsushi Mizota; Minoru Tanaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

6.  Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis.

Authors:  C Lemieux; G St-Germain; J Vincelette; L Kaufman; L de Repentigny
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Evaluation of a Candida antigen detection method (Cand-Tec): Experience from a university teaching hospital.

Authors:  T J Anderson; H E Bryant; D L Church
Journal:  Can J Infect Dis       Date:  1992-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.